Form D · Other Technology
Molecula Corp.
Austin, TX · CIK 0001758602
Offering snapshot reported Nov 16, 2022 · SEC filing
- Reported sold
- $6.24M Offering amount: $10.3M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 23, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2022 | Initial | $6,239,234 | No comparison | 24 | SEC filing |
| Jan 13, 2021 | Initial | $17,623,877 | No comparison | 42 | SEC filing |
| Aug 26, 2019 | Amendment | $5,962,512 | $2,290,623vs Nov 13, 2018 | 40 | SEC filing |
| Nov 13, 2018 | Initial | $3,671,889 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-464934
Source: Form D, filed Nov 16, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julie Dodd | Director |
| Clark Golestani | Director |
| Andrew Jenks | Director |
| Andy Jenks | Director |
| Higinio O Maycotte | Director, Executive |
| Thomas Meredith | Director |
| John Porter | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
301 West Avenue Suite 200
Austin, TX, 78701
Austin, TX, 78701